CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement Long-Term Outcomes of Anticoagulation for Bioprosthetic Valve Thrombosis Percutaneous Coronary Intervention Using Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Stenosis: A Meta-Analysis of Randomized Trials Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement Osteoarthritis risk is reduced after treatment with ticagrelor compared to clopidogrel: a propensity score matching analysis Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension)

Original ResearchVolume 73, Issue 9, March 2019

JOURNAL:J Am Coll Cardiol. Article Link

von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week

EV Belle, F Vincent, A Rauch et al. Keywords: aortic stenosis; biomarker; bioprosthesis; heart valve disease; mitral regurgitation; paravalvular regurgitation; point-of-care test; TAVR

FULL TEXT PDF